2020, Food and Drug Administration, Leads and Medical science

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2020

Food and Drug Administration

Leads

Medical science

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

DECEMBER 28, 2023

We received encouraging feedback from the US Food and Drug Administration (FDA) on the trial design and potential for accelerated approval. We also believe that bispecifics will further establish themselves as an important drug class in the treatment regimens for both haematological malignancies and solid tumours.

Food and Drug Administration

Food and Drug Administration Patients Safety Medical science

Moving towards oral delivery of biologics

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics.

Food and Drug Administration

Food and Drug Administration Manufacturing Safety Pharmaceutical

Pharma Rep Focus

Leveraging innate cell engagers for lymphoma treatment

Moving towards oral delivery of biologics

Stay Connected